4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride

4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride Struktur
388575-52-8
CAS-Nr.
388575-52-8
Englisch Name:
4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride
Synonyma:
PSN375963;PSN 375963 hydrochloride;5-(4-butylcyclohexyl)-3-pyridin-4-yl-1,2,4-oxadiazole;4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridine;Pyridine, 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-;4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride;Inhibitor,inhibit,PSN375963,receptor,PSN 375963,PSN-375963,G Protein-Coupled Receptor 119,endogenous,GPR119,ligand,orphan,cAMP
CBNumber:
CB12518900
Summenformel:
C17H23N3O
Molgewicht:
285.38
MOL-Datei:
388575-52-8.mol

4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride Eigenschaften

Siedepunkt:
440.1±47.0 °C(Predicted)
Dichte
1.060±0.06 g/cm3(Predicted)
storage temp. 
-20°C
Löslichkeit
DMSO: >10mg/mL
pka
0.82±0.10(Predicted)
Aggregatzustand
powder
Farbe
white to off-white

Sicherheit

WGK Germany  nwg

4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride Chemische Eigenschaften,Einsatz,Produktion Methoden

Biochem/physiol Actions

PSN-375963 is a GPR119 partial agonist. GPR119 is an orphan GPCR, expressed predominantly in pancreas and GI tract, that has been characterized. Its endogenous ligands are oleoylethanolamide (OEA) and oleoyl-lysophosphatidylcholine, lipid signaling molecules that regulate food intake and body weight. OEA decreases food intake, so GPR119 agonists are potential therapies for obesity. Initial studies showed that PSN-375963 has similar potency and partial efficacy compared to OEA. Further studies revealed that although OEA and PSN-375963 are GPR119 agonists, they have divergent effects on insulin secretion, calcium signaling, and cAMP production.

4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 42)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32480 60
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 52927 58
3B Pharmachem (Wuhan) International Co.,Ltd. 821-50328103-801 18930552037
3bsc@sina.com China 15848 69
Dalian Meilun Biotech Co., Ltd. 0411-62910999 13889544652
sales@meilune.com China 4647 58
LETOPHARM LIMITED +86-21-5821 5861
sales@letopharm.com China 2384 58
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51471 80
EMMX Biotechnology LLC 888-539-0666
info@emmx.com United States 8449 60
Angel Pharmatech, Ltd. 17317130613
3358272972@qq.com China 3237 58
BOC Sciences --
info@bocsci.com USA 0 65

  • 4-[5-(4-Butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridinehydrochloride
  • PSN 375963 hydrochloride
  • PSN375963
  • 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-pyridine
  • 5-(4-butylcyclohexyl)-3-pyridin-4-yl-1,2,4-oxadiazole
  • Inhibitor,inhibit,PSN375963,receptor,PSN 375963,PSN-375963,G Protein-Coupled Receptor 119,endogenous,GPR119,ligand,orphan,cAMP
  • Pyridine, 4-[5-(4-butylcyclohexyl)-1,2,4-oxadiazol-3-yl]-
  • 388575-52-8
  • C17H23N3OHCl
Copyright 2019 © ChemicalBook. All rights reserved